← All medicines
Budesonide Azure 0.5 mg/2 ml Nebuliser Suspension
Licence PA22871/035/001 · Not marketed
- Licence holder
- Azure Pharmaceuticals Ltd. (all products →)
- Active substance
- Budesonide
- Dosage form
- Nebuliser suspension
- Route of administration
- Inhalation use
- ATC code
- R03BA02
- First authorised
- 06/02/2026
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.